Showing results (321-330 of 452) with videos related to

Sort By:
Pageof 46
Current Radiopharmaceuticals|March 27, 2015
The Use of 68Ga-DOTA-(Tyr3)-Octreotate PET/CT for Improved Target Definition in Radiotherapy Treatment Planning of Meningiomas - A Case ReportHanna Grzbiela, Rafał Tarnawski, Andrea D'Amico, et al.
Current Radiopharmaceuticals|March 16, 2015
Consequences of meta-stable (177m)Lu admixture in (177)Lu for patient dosimetryMark W Konijnenberg
Current Radiopharmaceuticals|March 16, 2015
Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with (177)Lu and Conjugated to PeptidesGuillermina Ferro-Flores, Blanca E Ocampo-García, Clara L Santos-Cuevas, et al.
Current Radiopharmaceuticals|March 16, 2015
Pharmacokinetic, Dosimetry and Toxicity Study of ¹⁷⁷Lu-EDTMP in Patients: Phase 0/I studyChandrasekhar Bal, Geetanjali Arora, Praveen Kumar, et al.
Current Radiopharmaceuticals|March 16, 2015
Radiation Dosimetry Aspects of (177)LuMichael Lassmann, Uta Eberlein
Current Radiopharmaceuticals|March 16, 2015
Development and biological studies of ¹⁷⁷Lu-DOTA-rituximab for the treatment of Non-Hodgkin's lymphomaAdriana V F Massicano, Priscilla B Pujatti, Lais F Alcarde, et al.
Current Radiopharmaceuticals|June 16, 2012
Radioarsenic from a portable (72)Se/(72)As generator: a current perspectiveB Ballard, F M Nortier, E R Birnbaum, et al.
Current Radiopharmaceuticals|June 16, 2012
Yttrium-90 -- current status, expected availability and applications of a high beta energy emitterR Leyva Montaña, I Hernández González, A Alberti Ramirez, et al.
Pageof 46